Notably, we did not observe evidence that GAS1 had a similar effect on the risk of other molecular subtypes of breast cancer or on non-cancer phenotypes, which may imply GAS1 has a specific effect to increase TNBC risk. This evidence concerns the gene GAS1 and breast carcinoma.